INTERACTION OF NEUROLEPTIC AND MUSCARINIC AGENTS WITH CENTRAL DOPAMINERGIC SYSTEMS

被引：52

作者：

KELLY, PH

MILLER, RJ

机构：

[1] UNIV CAMBRIDGE,DEPT EXPTL PSYCHOL,DOWNING ST,CAMBRIDGE,ENGLAND

[2] UNIV CAMBRIDGE,MED SCH,DEPT PHARMACOL,MRC,NEUROCHEM PHARMACOL UNIT,HILLS RD,CAMBRIDGE CB2 2QD,ENGLAND

来源：

关键词：

D O I：

10.1111/j.1476-5381.1975.tb07417.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：115 / 121

页数：7

共 21 条

[11] KLAWANS HL, 1973, PHARMACOLOGY EXTRAPY
[12] MILLER RJ, 1974, MOL PHARMACOL, V10, P759
[13] ANTIMUSCARINIC PROPERTIES OF NEUROLEPTICS AND DRUG-INDUCED PARKINSONISM
MILLER, RJ
HILEY, CR
[J]. NATURE, 1974, 248 (5449) : 596 - 597
[14] Pellegrino L.J., 1967, STEREOTAXIC ATLAS RA
[15] SETHY VH, 1974, NATURE LOND, V251, P524
[16] EFFECTS OF ANTIPARKINSONIAN DRUGS ON NEUROLEPTIC-INDUCED EXTRAPYRAMIDAL SIGNS IN MONKEYS
SHINTOMI, K
YAMAMURA, M
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (08) : 666 - 667
[17] SNYDER S, 1974, ARCH GEN PSYCHIAT, V31, P58
[18] ENHANCED STRIATAL ACETYLCHOLINE RELEASE BY CHLORPROMAZINE AND ITS REVERSAL BY APOMORPHINE
STADLER, H
LLOYD, KG
GADEACIR.M
BARTHOLINI, G
[J]. BRAIN RESEARCH, 1973, 55 (02) : 476 - 480
[19] UNGERSTEDT U, 1970, BRAIN RES, V24, P486
[20] UNGERSTEDT U, 1973, ADV NEUROL, V3, P257